AQP4 expression in the muscles is markedly reduced in patients with dystrophinopathy, dysferlinopathy, and amyotrophic lateral sclerosis (ALS)[8-10], but the pathophysiology underlying the reduction in expression is unclear. Here, AQP4 is linked to amyotrophic lateral sclerosis.